Alpha Teknova (TKNO) EBT Margin Growth (1y) (2021 - 2026)
Alpha Teknova (TKNO) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 378.66 Mn | 361.23 Mn | 4.89 Mn | 875.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 875.00 |
| Mar 31, 2026 | 650.00 |
| Dec 31, 2025 | 1,386.00 |
| Sep 30, 2025 | 3,884.00 |
| Jun 30, 2025 | 2,136.00 |
| Mar 31, 2025 | 4,033.00 |
| Dec 31, 2024 | 7,718.00 |
| Sep 30, 2024 | 4,509.00 |
| Jun 30, 2024 | 606.00 |
| Mar 31, 2024 | 934.00 |
| Dec 31, 2023 | 3,923.00 |
| Sep 30, 2023 | 8,952.00 |
| Jun 30, 2023 | -549.00 |
| Mar 31, 2023 | -4,433.00 |
| Dec 31, 2022 | -13,066.00 |
| Sep 30, 2022 | -16,958.00 |
| Jun 30, 2022 | -2,236.00 |
| Mar 31, 2022 | -4,350.00 |
| Dec 31, 2021 | -5,587.00 |
| Sep 30, 2021 | -6,825.00 |